VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

SOHO 2022 | An insight into the standard of care in HR-MDS and future outlooks

In this video, David Sallman, MD, Moffitt Cancer Center, Tampa, FL, shares some insights into the standard of care in high-risk myelodysplastic syndromes (HR-MDS). Dr Sallman first comments on the role of hypomethylating agents (HMAs) such as azacitidine in this population, and further discusses the importance of allogeneic stem cell transplantation (alloSCT) and the growing role of combination approaches. This interview took place at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO) held in Houston, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter